Background illustration for clinical trials search

Migraine Clinical Trials

Browse 180 migraine clinical trials enrolling across the United States and Canada. 52 people applied to migraine studies last month. Search by city or state to find one near you.

Filter
1

SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism

for
Autistic Disorder, Autism Spectrum Disorder,
Location: Louisville KY
Sponsor: American Federation of Medical Synergetics

Sex: All

Age: 0 - 21

Code: NCT03222375

Recruiting

Rett Syndrome Registry

for
Rett Syndrome, Rett Syndrome, Atypical, Genetic Disease,
Location: Boston MA, Philadelphia PA, Baltimore MD,
Sponsor: International Rett Syndrome Foundation

Sex: All

Age: 0 - 70+

Code: NCT05432349

Recruiting

Cereset Research Exploratory Study

for
Neurological Diseases or Conditions,
Location: Winston-Salem NC
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 11+

Code: NCT03777267

Recruiting

Automating Delirium Severity in the ICU

for
Intensive Care Unit Delirium, Encephalopathy, Delirium
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 50+

Code: NCT06172491

Recruiting
New

Virtual Reality and Biofeedback for Adolescents With Chronic Dizziness

for
Persistent Postural Perceptual Dizziness, Vestibular Migraine,
Location: Waltham MA
Sponsor: Boston Children's Hospital

Sex: All

Age: 13 - 25

Code: NCT07374640

Early Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Efficacy of Sumatriptan With Naprosyn in Migraine With Aura

for
Migraine With Aura
Location: Amherst NY
Sponsor: Dent Neurologic Institute

Sex: All

Age: 18 - 50

Code: NCT00893594

Recruiting
Active & Responsive

Pilot Study for a Machine Learning Test for Migraine

for
Migraine, Chronic Migraine, Tension-Type Headache
Location: Toronto
Sponsor: Headache Sciences Incorporated

Sex: All

Age: 18 - 70

Code: NCT05517200

Not recruiting

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

for
Post-Acute COVID-19 Syndrome, ME/CFS, Rheumatic Arthritis,
Location: Delafield WI
Sponsor: Brain Inflammation Collaborative

Sex: All

Age: 2+

Code: NCT04806620

Recruiting

Study of Low-level Laser Therapy in the Acute Treatment of Migraine

for
Migraine Headache
Location: San Francisco CA
Sponsor: The San Francisco Clinical Research Center

Sex: All

Age: 18+

Code: NCT02969642

Phase 2, Recruiting

Prevention of Menstrual Migraines: Effects of Estrogen Add-back During the HFI in Patients Using Continuous Oral Contraceptives.

for
Menstrual Migraines, Menstrual Bleeding, Menstrual Spotting
Location: Temple TX
Sponsor: Scott and White Hospital & Clinic

Sex: Female

Age: 18 - 45

Code: NCT01251263

Recruiting

Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea

for
Dysmenorrhea, Headache, Migraine, Fatigue, Nausea,
Location: Sterling Heights MI
Sponsor: Pure Green

Sex: Female

Age: 21+

Code: NCT04091789

Phase 2, Recruiting

Treximet in Acute Migraine Headache: Assessing Cognitive Function

for
Migraine Headache, Cognitive Impairment
Location: Bennington VT
Sponsor: Neurological Research Center

Sex: All

Age: 18 - 65

Code: NCT00837044

Recruiting

BE WELL With Migraine: Brain Education and WELLness With Migraine

for
Migraine
Location: Winston-Salem NC
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 18+

Code: NCT05987592

Recruiting
New

A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping

for
Muscular Dystrophies,
Location: London
Sponsor: Avidity Biosciences, Inc.

Sex: Male

Age: 7 - 16

Code: NCT07587242

Phase 3, Recruiting

A Multicenter Pediatric Deep Brain Stimulation Registry

for
Dystonia, Epilepsy in Children, Cerebral Palsy,
Location: Boston MA
Sponsor: Boston Children's Hospital

Sex: All

Age: 0 - 18

Code: NCT06585618

Recruiting

Post Hoc Analysis and Clinical Data Collection for Subjects Tested With Brain Network Activation (BNA™) Technology

for
Healthy, Cognitive Impairment, Neurological Disorder
Location: Chicago IL, Skokie IL
Sponsor: ElMindA Ltd

Sex: All

Age: 8 - 70+

Code: NCT03699514

Recruiting

Brain Health in the Time of COVID-19

for
Brain Health
Location: San Francisco CA
Sponsor: Miro Health

Sex: All

Age: 18+

Code: NCT04438967

Recruiting

Wearable Devices and Biomarkers Project (Healthiomics)

for
Brain Cancer, Neurological Disorder, Neurological Cancer
Location: San Diego CA
Sponsor: CureScience

Sex: All

Age: 18+

Code: NCT05106725

Recruiting

Ask Questions About Clinical Trials

for
Oncology, Cardiac Disease, Neurologic Disorder
Location: Port Huron MI, Mount Clemens MI, Lapeer MI,
Sponsor: Barbara Ann Karmanos Cancer Institute

Sex: All

Age: 18+

Code: NCT07343297

Recruiting

Product Surveillance Registry

for
Cardiac Rhythm Disorders, Urological Disorders,
Location: Boston MA, Riverhead NY, Hartford CT, Holyoke MA,
Sponsor: Medtronic

Sex: All

Age: 0+

Code: NCT01524276

Recruiting

What is migraine?

Migraine is a brain condition, not a blood vessel problem or a stress reaction. An attack usually brings throbbing pain on one side of the head, along with nausea and sensitivity to light and sound, and it can last from a few hours to three days. About 1 in 4 people with migraine get an aura first, visual disturbances like flashing lights or zigzag lines that come before the pain. Doctors sort migraine by frequency: episodic means fewer than 15 headache days a month, chronic means 15 or more, with at least 8 of them migraine days, for more than three months.

For most of medical history, migraine was treated with medicines borrowed from other conditions: blood pressure pills, antidepressants, epilepsy drugs. That changed in 2018, when the first medicine designed specifically for migraine was approved. It blocks a molecule called CGRP, which the brain releases during an attack. There are now four CGRP antibodies given by injection and several CGRP blocking pills, called gepants, and they treat both attacks and prevention. In a 2025 real world study of more than 2,000 patients, about 47 percent of people on a CGRP antibody had a meaningful response at three months, compared with about 35 percent on traditional preventives.

Types of migraine clinical trials

Who can participate in migraine clinical trials?

Episodic and chronic migraine, and why the line matters for trials

Do migraine trial participants get paid?

What is the difference between a migraine and a headache?

How to Enroll in a Clinical Trial for Migraine